Molecular Cyclotrons

Molecular Cyclotrons is a biotechnology company pioneering the field of Green Nanotechnology to create advanced radiopharmaceuticals and diagnostic imaging agents. The company utilizes a proprietary platform that employs phytochemicals and natural extracts to synthesize biocompatible gold nanoparticles without the use of toxic chemicals. These nanoparticles are engineered to carry therapeutic radioisotopes, such as Gold-198, directly to tumor sites, particularly for the treatment of prostate and breast cancers. By combining nuclear medicine with nanotechnology, Molecular Cyclotrons aims to develop highly targeted therapies that minimize systemic side effects. The company's research is deeply rooted in the work of its founder, Dr. Kattesh Katti, at the University of Missouri.